Grey Michael G
SEC-identified person · CIK 1240122 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Mirum Pharmaceuticals, Inc. MIRM | Director · Executive Chairman | filed 2019 - 2026 |
| Reneo Pharmaceuticals, Inc. RPHM | Director · Executive Chairman | filed 2021 - 2026 |
| Spruce Biosciences, INC. SPRB | Director · Executive Chairman | filed 2020 - 2026 |
| Horizon Therapeutics Public Ltd Co HZNP | Director | filed 2011 - 2023 |
| Biomarin Pharmaceutical INC BMRN | Director | filed 2006 - 2021 |
| Mirati Therapeutics, Inc. mrtx | Director | filed 2014 - 2021 |
| Achillion Pharmaceuticals INC ACHN | Director | filed 2006 - 2009 |
| IDM Pharma, INC. idmi | Director | filed 2006 - 2008 |
| SGX Pharmaceuticals, INC. sgxp | Director · President and CEO | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.